These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. Song GA; Kim HJ; Woo KM; Baek JH; Kim GS; Choi JY; Ryoo HM J Biol Chem; 2010 Jul; 285(29):22542-53. PubMed ID: 20463014 [TBL] [Abstract][Full Text] [Related]
10. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Kaplan FS; Xu M; Seemann P; Connor JM; Glaser DL; Carroll L; Delai P; Fastnacht-Urban E; Forman SJ; Gillessen-Kaesbach G; Hoover-Fong J; Köster B; Pauli RM; Reardon W; Zaidi SA; Zasloff M; Morhart R; Mundlos S; Groppe J; Shore EM Hum Mutat; 2009 Mar; 30(3):379-90. PubMed ID: 19085907 [TBL] [Abstract][Full Text] [Related]
11. Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery. Yang YS; Kim JM; Xie J; Chaugule S; Lin C; Ma H; Hsiao E; Hong J; Chun H; Shore EM; Kaplan FS; Gao G; Shim JH Nat Commun; 2022 Oct; 13(1):6175. PubMed ID: 36258013 [TBL] [Abstract][Full Text] [Related]
12. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Hatsell SJ; Idone V; Wolken DM; Huang L; Kim HJ; Wang L; Wen X; Nannuru KC; Jimenez J; Xie L; Das N; Makhoul G; Chernomorsky R; D'Ambrosio D; Corpina RA; Schoenherr CJ; Feeley K; Yu PB; Yancopoulos GD; Murphy AJ; Economides AN Sci Transl Med; 2015 Sep; 7(303):303ra137. PubMed ID: 26333933 [TBL] [Abstract][Full Text] [Related]
13. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819 [TBL] [Abstract][Full Text] [Related]
14. ACVR1-Fc suppresses BMP signaling and chondro-osseous differentiation in an in vitro model of Fibrodysplasia ossificans progressiva. Pang J; Zuo Y; Chen Y; Song L; Zhu Q; Yu J; Shan C; Cai Z; Hao J; Kaplan FS; Shore EM; Zhang K Bone; 2016 Nov; 92():29-36. PubMed ID: 27492611 [TBL] [Abstract][Full Text] [Related]
15. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related]
16. Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva. Shi S; Cai J; de Gorter DJ; Sanchez-Duffhues G; Kemaladewi DU; Hoogaars WM; Aartsma-Rus A; 't Hoen PA; ten Dijke P PLoS One; 2013; 8(7):e69096. PubMed ID: 23861958 [TBL] [Abstract][Full Text] [Related]
17. The Fibrodysplasia Ossificans Progressiva (FOP) mutation p.R206H in ACVR1 confers an altered ligand response. Hildebrand L; Stange K; Deichsel A; Gossen M; Seemann P Cell Signal; 2017 Jan; 29():23-30. PubMed ID: 27713089 [TBL] [Abstract][Full Text] [Related]
18. Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the Zebrafish. Allen RS; Jones WD; Hale M; Warder BN; Shore EM; Mullins MC J Bone Miner Res; 2023 Sep; 38(9):1364-1385. PubMed ID: 37329499 [TBL] [Abstract][Full Text] [Related]
19. Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva. Chakkalakal SA; Shore EM Methods Mol Biol; 2019; 1891():247-255. PubMed ID: 30414138 [TBL] [Abstract][Full Text] [Related]
20. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP). Wang H; Shore EM; Pignolo RJ; Kaplan FS Bone; 2018 Apr; 109():218-224. PubMed ID: 29170109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]